Prevention of preeclampsia
- PMID: 23316362
- PMCID: PMC3534321
- DOI: 10.1155/2012/435090
Prevention of preeclampsia
Abstract
Preeclampsia (PE) affects around 2-5% of pregnant women. It is a major cause of maternal and perinatal morbidity and mortality. In an attempt to prevent preeclampsia, many strategies based on antenatal care, change in lifestyle, nutritional supplementation, and drugs have been studied. The aim of this paper is to review recent evidence about primary and secondary prevention of preeclampsia.
References
-
- WHO. Risking death to give life. World Health Organization, Geneva, Switzerland, 2005.
-
- Gifford RW, August PA, Cunningham G, et al. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. American Journal of Obstetrics and Gynecology. 2000;183(1):S1–S22. - PubMed
-
- Redman CWG, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. American Journal of Obstetrics and Gynecology. 1999;180(2):499–506. - PubMed
-
- Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. The Lancet. 2005;365(9461):785–799. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical